CK0801 - Cellenkos
Jakafi oral (ruxolitinib) - Novartis, Incyte
https://eventpilot.us/web/page.php?page=Session&project=ASH21&id=153864
 
Tapan M. Kadia, MD1; Naveen Pemmaraju, MD2; Musa Yilmaz, MD2; Naval Daver, MD3; Li Li, M.D.4; Mi-Ae Lyu, Ph.D.4; Meixian Huang, M.D., Ph.D.4; Ke Zeng, M.D.4; Robin Cook, RN2; Simrit Parmar, MBBS5; Siddhartha Mukherjee, MD, PhD6; Tara Sadeghi7; Courtney D. DiNardo, MD, MSCE2; Ghayas C. Issa, MD2; Elias J. Jabbour, MD2; Gautam Borthakur, MD8; Nitin Jain, MD9; Srdan Verstovsek, MD, PhD1
 
Nov 5, 2021
 
Prev Next